Effects of three months of low molecular weight heparin (dalteparin) treatment after bypass surgery for lower limb ischemia--a randomised placebo-controlled double blind multicentre trial.
Jivegård L, Drott C, Gelin J, Groth O, Hensäter M, Jensen N, Johansson G, Konrad P, Lindberg B, Lindhagen A, Lundqvist B, Oden A, Smith L, Stenberg B, Thornell E, Wingren U, Ortenwall P.
Eur J Vasc Endovasc Surg. 2005 Feb;29(2):190-8.PMID: 15649728 [PubMed - indexed for MEDLINE]Related articles